Intracellular accumulation of β-amyloid1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease

Neuroscience

Volumn 110, Issue 2, 2002, Pages 199-211

  Nagele, R G ^a   D'Andrea, M R ^b   Anderson, W J ^a   Wang, H Y ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

A 42; Amyloid plaque; Endocytosis; Neuroblastoma; Nicotinic acetylcholine receptor; Pyramidal cell

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; ARSENOSOBENZENE; NICOTINIC RECEPTOR; PEPTIDE; RECEPTOR BLOCKING AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN NERVE CELL; CELL ASSAY; CELL CULTURE; CELL LEVEL; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTERNALIZATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BINDING SITES; CYTOPLASM; ENDOCYTOSIS; ENTORHINAL CORTEX; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HUMANS; NEURONS; PEPTIDE FRAGMENTS; RECEPTORS, NICOTINIC; SENILE PLAQUES; TUMOR CELLS, CULTURED;

EID: 0037066072     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00460-2     Document Type: Article

References (76)

1. Cellular expression of α7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease: A stereological approach
2. Somatostatin-induced regulation of SST(2A) receptor expression and cell surface availability in central neurons: Role of receptor internalization
3. Neuropathological staging of Alzheimer-related changes
4. 125I]α-bungarotoxin binding in human postmortem brain
5. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ 1-42, in differentiated PC12 cells
6. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients
7. Neuron loss in APP transgenic mice
8. Enzymatically active lyosomal proteases are associated with amyloid deposits in Alzheimer brain
9. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit
10. Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities
11. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX
12. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease
13. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
14. The pathogenesis of senile plaques
15. The neurobiology and pharmacotherapy of Alzheimer's disease
16. Phenylarsine oxide inhibition of endocytosis: Effects of asailofetuin internalization
17. RNA sequestration to pathological lesions of neurodegenerative diseases
18. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
19. Intraneuronal Aβ42 accumulation in human brain
20. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
21. Amyloid, the presenilins and Alzheimer's disease
22. Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides
23. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
24. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
25. Rapid cellular uptake of Alzheimer's amyloid βA4 peptide by cultured human neuroblastoma cells
26. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor
27. The cholinergic system in Alzheimer's disease
28. The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: Studies with DMXBA (GTS-21)
29. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/B protein
30. Endocytosis and recycling of G-protein-coupled receptors
31. Decreased α7 nicotinic acetylcholine receptor levels in sporadic Alzheimer's disease hippocampus
32. Characterization of the neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells
33. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer
34. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein
35. Amyloid plaque core protein in Alzheimer disease and Down syndrome
36. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease
37. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
38. Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells; possible function in insulin processing in the blood-brain barrier
39. Making the diagnosis of Alzheimer's disease
40. Multiple pathways for ligand internalization in rat hepatocytes I: Effects of anoxia, phenylarsine oxide and monensin
41. Precise spatial positioning of chromosomes during prometaphase: Evidence for chromosome order
42. Chromosomes exhibit preferential positioning in quiescent human cells
43. Telomere associations in interphase nuclei: Possible role in maintenance of interphase chromosome topology
44. Alzheimer's disease: A re-examination of the amyloid hypothesis
45. Neuroreceptor changes in Alzheimer's disease
46. Human nicotinic receptors- their role in aging and dementia
47. Neuronal nicotinic receptors in the human brain
48. Inducible, heterologous expression of human α7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line
49. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice
50. Selective binding of soluble Aβ1-40 and Aβ1-42 to a subset of senile plaques
51. Modulation of α7 nicotinic receptor-mediated calcium influx by nicotinic agonists
52. The presence, origin and significance of Aβ peptide in the cell bodies of neurons
53. Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunit β 3 and β 4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32
54. Nicotinic acetylcholine receptors in Alzheimer's disease
55. Molecular cloning, functional properties, and distribution of rat brain α 7: A nicotinic cation channel highly permeable to calcium
56. The molecular pathology of Alzheimer's disease
57. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
58. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture
59. Age-related amyloid B deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid B precursor protein Swedish mutant is not associated with global neuronal loss
60. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier
61. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons
62. Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation
63. Distinct sites of intracellular production for Alzheimer's disease A β40/42 amyloid peptides
64. Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells
65. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity: Implications for Alzheimer's disease pathology
66. Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors
67. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: Postmortem investigations and experimental approaches
68. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: Histotopographical correlation with amyloid plaques and hyperphosphorylated tau protein
69. Nicotinic receptors and neurodegenerative dementing diseases: Basic research and clinical implications
70. Intracellular generation and accumulation of amyloid B-peptide terminating at amino acid 42
71. Intracellular APP processing and A β production in Alzheimer disease
72. Biology of Aβ amyloid in Alzheimer's disease
73. Occurrance of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
74. Mechanisms of neuronal degeneration in Alzheimer's disease
75. Evidence that Aβ42 is the real culprit in Alzheimer's disease